A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
We endeavor to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence, or AI, in healthcare. Intelligent Diagnostics use AI, including generative and agentic AI, to make laboratory tests more accurate, tailored, and personal. We make tests intelligent by connecting laboratory results to a patient’s own clinical data, thereby personalizing the results. Our novel insight was realizing that all laboratory test results, genomic or otherwise, could be contextualized for a specific patient based upon that patient’s unique characteristics, and technology could therefore guide therapy selection and treatment decisions to allow each patient to progress on their own unique path.
| Metric | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | 1.3B | 1.3B | 693M | 532M |
| Net Income | -245M | -245M | -746M | -266M |
| EPS | $-1.41 | $-1.41 | $-6.23 | $-4.20 |
| Free Cash Flow | -239M | -239M | -211M | -249M |
| ROIC | -70.6% | -53.0% | -59.0% | -34.8% |
| Gross Margin | 69.6% | 69.6% | 64.9% | 64.4% |
| Debt/Equity | 0.81 | 0.81 | 3.57 | -0.17 |
| Dividends/Share | $0.00 | $0.00 | $0.05 | $0.03 |
| Operating Income | -253M | -253M | -691M | -196M |
| Operating Margin | -19.9% | -19.9% | -99.7% | -36.9% |
| ROE | -49.9% | -89.5% | -1324.7% | - |
| Shares Outstanding | 174M | 174M | 120M | 172M |
| Metric | 2023 | |||
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 532M | 693M | 1.3B | 1.3B |
| Gross Margin | 64.4% | 64.9% | 69.6% | 69.6% |
| R&D | 90M | 149M | 173M | 173M |
| SG&A | 297M | 755M | 732M | 732M |
| EBIT | -196M | -691M | -253M | -253M |
| Op. Margin | -36.9% | -99.7% | -19.9% | -19.9% |
| Net Income | -266M | -746M | -245M | -245M |
| Net Margin | -50.0% | -107.6% | -19.3% | -19.3% |
| Non-Recurring | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||
| ROIC | -34.8% | -59.0% | -53.0% | -70.6% |
| ROE | N/A | -1324.7% | -89.5% | -49.9% |
| ROA | -47.2% | -80.6% | -15.3% | -10.8% |
| Cash Flow | ||||
| Op. Cash Flow | -214M | -189M | -218M | -218M |
| Free Cash Flow | -249M | -211M | -239M | -239M |
| Owner Earnings | -247M | -760M | -445M | -445M |
| CapEx | 35M | 22M | 21M | 21M |
| Maint. CapEx | 33M | 37M | 102M | 102M |
| Growth CapEx | 1.6M | 0 | 0 | 0 |
| D&A | 33M | 37M | 102M | 102M |
| CapEx/OCF | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||
| Dividends Paid | 5.6M | 5.6M | 0 | 0 |
| Dividend Yield | N/A | 0.1% | N/A | N/A |
| Share Buybacks | 3.6M | 0 | 3.0M | 3.0M |
| Buyback Yield | N/A | N/A | 0.0% | 0.0% |
| Stock-Based Comp | 0 | 534M | 125M | 125M |
| Debt Repayment | 698K | 0 | 277M | 277M |
| Balance Sheet | ||||
| Net Debt | -100M | -481M | -813M | -208M |
| Cash & Equiv. | 166M | 341M | 605M | 605M |
| Long-Term Debt | 193M | 168M | 209M | 209M |
| Debt/Equity | -0.17 | 3.57 | 0.81 | 0.81 |
| Interest Coverage | -4.2 | -12.9 | -3.6 | -3.6 |
| Equity | -1.4B | 56M | 491M | 491M |
| Total Assets | 564M | 926M | 2.3B | 2.3B |
| Total Liabilities | 1.9B | 870M | 1.8B | 1.8B |
| Intangibles | 22M | 12M | 355M | 355M |
| Retained Earnings | -1.4B | -2.2B | -2.4B | -2.4B |
| Working Capital | 118M | 377M | 795M | 795M |
| Current Assets | 350M | 668M | 1.2B | 1.2B |
| Current Liabilities | 233M | 291M | 372M | 372M |
| Per Share Data | ||||
| EPS | -4.20 | -6.23 | -1.41 | -1.41 |
| Owner EPS | -1.44 | -6.35 | -2.56 | -2.56 |
| Book Value | -8.03 | 0.47 | 2.83 | 2.83 |
| Cash Flow/Share | -1.24 | -1.58 | -1.25 | -0.82 |
| Dividends/Share | 0.03 | 0.05 | 0.00 | 0.00 |
| Shares Out. | 172.2M | 119.8M | 173.8M | 173.8M |
| Valuation | ||||
| P/E Ratio | N/A | N/A | N/A | -35.1 |
| P/FCF | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A |
| Price/Book | N/A | 74.7 | 22.2 | 17.5 |
| Price/Sales | N/A | 8.1 | 8.9 | 6.8 |
| FCF Yield | N/A | -5.0% | -2.2% | -2.8% |
| Market Cap | N/A | 4.2B | 10.9B | 8.6B |
| Avg. Price | N/A | 47.03 | 64.94 | 49.53 |
| Year-End Price | N/A | 35.12 | 62.70 | 49.53 |
Tempus AI, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 66.3%.
Tempus AI, Inc. (TEM) has a 5-year average return on invested capital (ROIC) of -48.9%. This is below average and may indicate limited pricing power.
Tempus AI, Inc. (TEM) has a market capitalization of $8.6B. It is classified as a mid-cap stock.
Tempus AI, Inc. (TEM) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.04%.
Tempus AI, Inc. (TEM) operates in the Services-Computer Programming, Data Processing, Etc. industry, within the Technology sector.
Tempus AI, Inc. (TEM) reported annual revenue of $1.3 billion in its most recent fiscal year, based on SEC EDGAR filings.
Tempus AI, Inc. (TEM) has a net profit margin of -19.3%. The company is currently unprofitable.
Tempus AI, Inc. (TEM) generated $-239 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Tempus AI, Inc. (TEM) has a debt-to-equity ratio of 0.81. This indicates moderate leverage.
Tempus AI, Inc. (TEM) reported earnings per share (EPS) of $-1.41 in its most recent fiscal year.
Tempus AI, Inc. (TEM) has a return on equity (ROE) of -89.5%. A negative ROE may indicate losses or negative equity.
Tempus AI, Inc. (TEM) has a 5-year average gross margin of 66.3%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 3 years of financial data for Tempus AI, Inc. (TEM), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Tempus AI, Inc. (TEM) has a book value per share of $2.83, based on its most recent annual SEC filing.